Chelsey Schneider
Nurse Practitioner · Bismarck, NDNPI 1992068555
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$519
- E.r. Squibb & Sons, L.L.C.$322
- Amgen$286
- Novartis$217
- Boehringer Ingelheim$181
- Johnson & Johnson$101
- plus $544 from 15 others
What the payments were for
- Food & beverage$2,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 35 | $519 |
| E.r. Squibb & Sons, L.L.C. | 24 | $322 |
| Amgen | 15 | $286 |
| Novartis | 17 | $217 |
| Boehringer Ingelheim | 10 | $181 |
| Johnson & Johnson | 7 | $101 |
| Lexicon Pharmaceuticals, Inc. | 5 | $79 |
| Merck | 5 | $71 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $55 |
| Daiichi Sankyo Inc. | 3 | $48 |
| Alnylam Pharmaceuticals Inc. | 3 | $47 |
| Itamar Medical Inc | 1 | $41 |
| Novo Nordisk | 2 | $33 |
| Philips North America LLC | 1 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $28 |
| AbbVie | 1 | $24 |
| Abbott | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Medtronic | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$2,170 in reported general payments places this provider in the 90th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 892 | $779,653 |
| XareltoRivaroxaban | 296 | $271,925 |
| Repatha SureclickEvolocumab | 154 | $89,963 |
| EntrestoSacubitril/Valsartan | 84 | $86,418 |
| JardianceEmpagliflozin | 92 | $80,348 |
| Praluent PenAlirocumab | 85 | $49,703 |
| Metoprolol Succinate | 1,590 | $30,802 |
| Rosuvastatin Calcium | 1,164 | $20,491 |
| Atorvastatin Calcium | 1,378 | $18,445 |
| Ezetimibe | 468 | $11,317 |
| FarxigaDapagliflozin Propanediol | 12 | $9,180 |
| BrilintaTicagrelor | 11 | $8,717 |
| Carvedilol | 595 | $7,238 |
| ClopidogrelClopidogrel Bisulfate | 501 | $7,146 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 190 | $7,066 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $519 | $779,653892 claims |
| Johnson & JohnsonXarelto | $101 | $271,925296 claims |
| NovartisEntresto | $217 | $86,41884 claims |
| Boehringer IngelheimJardiance | $181 | $80,34892 claims |
| AstraZenecaFarxiga, Brilinta | $14 | $17,89723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Bismarck
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
- Cassie HoltBismarck$5K
- Katherine CarvellBismarck$5K
- Shih Ru MartinBismarck$5K
- Janel OlsonBismarck$4K
- Mallorie EmoryBismarck$3K
- Kayla CoferBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.